Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Sankyo isolates antibacterial agent F-12436

Oct. 23, 1997

PathoGenesis initiates phase II trial with new antiinfective for tuberculosis

Oct. 22, 1997

New nonimmunosuppressive CsA derivative with potent anti-Toxoplasma activity

Oct. 22, 1997

Taisho, Abbott to collaborate on macrolide antibacterials

Oct. 21, 1997

NIH researcher outlines ups and downs of malaria vaccine research

Oct. 21, 1997

Anti-Infective Drugs Advisory Committee to discuss three NDAs

Oct. 20, 1997

Viragen considers genital herpes as possible target for Omniferon

Oct. 20, 1997

Cefluprenam: basic and clinical research on new injectable cephalosporin

Oct. 20, 1997

Shire files IND for new formulation of aciclovir

Oct. 20, 1997

CS-834: a new oral carbapenem in active development at Sankyo

Oct. 17, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...